Home / XTLB.TA : TLV

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does XTLB.TA make money? Does XTLB.TA have pricing power? What's the Earnings Whisper? Will XTLB.TA profit more as the business scales? What is XTLB.TA's management track record? Is XTLB.TA's current price justified?

XTL Biopharmaceuticals Ltd.

ILA 1.40 -$0.80 (-36.36%)

TLV · 30 Oct 2026 11:10 UTC

Previous Close

ILA 1.40

Day Range

ILA 1.40ILA 1.50

Year Range

ILA 0.02ILA 4.40

Market Cap

13.76M

AVG Volume

2.28M

Trailing/Forward PE

-0.56/-

PEG ratio

0.01

Dividend Yield

Next Earnings Date

Primary Exchange

Tel Aviv Stock Exchange

Revenue (USD) · A

XTLB.TA Revenue (USD) by year
Period	Revenue (USD)
2024	451K
2023	0
2022	0
2021	0
2020	0
2019	0
2018	0
2017	0
2016	0
2015	0

Net Income (USD) · A

XTLB.TA Net Income (USD) by year
Period	Net Income (USD)
2024	-1.03M
2023	-1.78M
2022	-1.35M
2021	1.01M
2020	-1.29M
2019	-1.35M
2018	2.99M
2017	-781K
2016	-2.54M
2015	-4.31M

Operating Income (USD) · A

XTLB.TA Operating Income (USD) by year
Period	Operating Income (USD)
2024	-2.17M
2023	-765K
2022	-880K
2021	-1.5M
2020	-1.21M
2019	-842K
2018	-793K
2017	-1.25M
2016	-2.56M
2015	-3.61M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (USD) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.

No video analysis for this stock yet. Request one from our team.

AI Analysis

XTL Biopharmaceuticals Ltd.

Earnings: XTLB.TA

Video analysis: XTLB.TA

News: XTLB.TA

Similar companies